PMC:7597510 / 11590-12116 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T103","span":{"begin":19,"end":27},"obj":"Disease"},{"id":"T104","span":{"begin":213,"end":236},"obj":"Disease"}],"attributes":[{"id":"A103","pred":"mondo_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A104","pred":"mondo_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"}],"text":"I was anxious when COVID-19 symptoms improved and neurological symptoms such as numbness and weakness developed. My symptoms gradually progressed and peaked in about 3–4 weeks. My doctor told me that I might have Guillain-Barré syndrome. I was told about gamma globulin treatment, but I declined that option due to the risk of side effects and the mild nature of my symptoms. After that, the symptoms gradually improved and the weakness disappeared, although the numbness remained. I was satisfied with the treatment protocol."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T95","span":{"begin":113,"end":115},"obj":"http://purl.obolibrary.org/obo/CLO_0050475"},{"id":"T96","span":{"begin":166,"end":169},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T97","span":{"begin":177,"end":179},"obj":"http://purl.obolibrary.org/obo/CLO_0050475"},{"id":"T98","span":{"begin":192,"end":194},"obj":"http://purl.obolibrary.org/obo/CLO_0007653"},{"id":"T99","span":{"begin":363,"end":365},"obj":"http://purl.obolibrary.org/obo/CLO_0050475"}],"text":"I was anxious when COVID-19 symptoms improved and neurological symptoms such as numbness and weakness developed. My symptoms gradually progressed and peaked in about 3–4 weeks. My doctor told me that I might have Guillain-Barré syndrome. I was told about gamma globulin treatment, but I declined that option due to the risk of side effects and the mild nature of my symptoms. After that, the symptoms gradually improved and the weakness disappeared, although the numbness remained. I was satisfied with the treatment protocol."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T67","span":{"begin":255,"end":260},"obj":"Chemical"}],"attributes":[{"id":"A67","pred":"chebi_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/CHEBI_30212"}],"text":"I was anxious when COVID-19 symptoms improved and neurological symptoms such as numbness and weakness developed. My symptoms gradually progressed and peaked in about 3–4 weeks. My doctor told me that I might have Guillain-Barré syndrome. I was told about gamma globulin treatment, but I declined that option due to the risk of side effects and the mild nature of my symptoms. After that, the symptoms gradually improved and the weakness disappeared, although the numbness remained. I was satisfied with the treatment protocol."}

{"project":"LitCovid-PubTator","denotations":[{"id":"248","span":{"begin":6,"end":13},"obj":"Disease"},{"id":"249","span":{"begin":19,"end":27},"obj":"Disease"},{"id":"250","span":{"begin":50,"end":71},"obj":"Disease"},{"id":"251","span":{"begin":80,"end":101},"obj":"Disease"},{"id":"252","span":{"begin":428,"end":436},"obj":"Disease"},{"id":"253","span":{"begin":463,"end":471},"obj":"Disease"}],"attributes":[{"id":"A248","pred":"tao:has_database_id","subj":"248","obj":"MESH:D001007"},{"id":"A249","pred":"tao:has_database_id","subj":"249","obj":"MESH:C000657245"},{"id":"A250","pred":"tao:has_database_id","subj":"250","obj":"MESH:D009422"},{"id":"A251","pred":"tao:has_database_id","subj":"251","obj":"MESH:D006987"},{"id":"A252","pred":"tao:has_database_id","subj":"252","obj":"MESH:D018908"},{"id":"A253","pred":"tao:has_database_id","subj":"253","obj":"MESH:D006987"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"I was anxious when COVID-19 symptoms improved and neurological symptoms such as numbness and weakness developed. My symptoms gradually progressed and peaked in about 3–4 weeks. My doctor told me that I might have Guillain-Barré syndrome. I was told about gamma globulin treatment, but I declined that option due to the risk of side effects and the mild nature of my symptoms. After that, the symptoms gradually improved and the weakness disappeared, although the numbness remained. I was satisfied with the treatment protocol."}

{"project":"LitCovid-sentences","denotations":[{"id":"T104","span":{"begin":0,"end":112},"obj":"Sentence"},{"id":"T105","span":{"begin":113,"end":176},"obj":"Sentence"},{"id":"T106","span":{"begin":177,"end":237},"obj":"Sentence"},{"id":"T107","span":{"begin":238,"end":375},"obj":"Sentence"},{"id":"T108","span":{"begin":376,"end":481},"obj":"Sentence"},{"id":"T109","span":{"begin":482,"end":526},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"I was anxious when COVID-19 symptoms improved and neurological symptoms such as numbness and weakness developed. My symptoms gradually progressed and peaked in about 3–4 weeks. My doctor told me that I might have Guillain-Barré syndrome. I was told about gamma globulin treatment, but I declined that option due to the risk of side effects and the mild nature of my symptoms. After that, the symptoms gradually improved and the weakness disappeared, although the numbness remained. I was satisfied with the treatment protocol."}